PHYLLIS TARALLO: Open Payments
NPI 1043217300 · TEANECK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,989 in 197 payments from 28 companies in 2025. Trend: 2023 $690 · 2024 $913 · 2025 $3,989
Food & beverage: $3,172Education: $418Long term medical supply or device loan: $399
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $606 |
| Daiichi Sankyo Inc. | 25 | $423 |
| E.R. Squibb & Sons, L.L.C. | 34 | $413 |
| GlaxoSmithKline, LLC. | 9 | $305 |
| Gilead Sciences, Inc. | 7 | $264 |
| Incyte Corporation | 7 | $208 |
| AstraZeneca Pharmaceuticals LP | 11 | $186 |
| Janssen Biotech, Inc. | 13 | $183 |
| Regeneron Healthcare Solutions, Inc. | 14 | $164 |
| TAIHO ONCOLOGY, INC. | 8 | $155 |
Products named: KISQALI, ENHERTU, Trodelvy, OJJAARA, LIBTAYO, LONSURF, OPDIVO, VERZENIO.
Industry payments across NJ — which companies pay providers there.
